Brief: Dermapharm repurchases 4,299,190 shares
March 27 (Reuters) - Dermapharm SE DMPG.DE: SAID ON FRIDAY: DERMAPHARM HOLDING SE - REPURCHASES 4,299,190 SHARES UNDER PUBLIC SHARE BUYBACK OFFER OFFER PRICE EXPECTED IN CUSTODIAN ACCOUNTS BY APRIL 2, 2026 INTENDS TO CANCEL BOUGHT TREASURY SHARES Further company coverage: [DMPG.DE] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Dermapharm Holding SE
See all newsBrief: Dermapharm Confirms 2026 Forecast
Corrected: Germany's Dermapharm prelim H1 revenue rises, maintains outlook
Brief: Dermapharm Holding - Confirms Full-Year Guidance For 2026
Brief: Dermapharm Spokesperson - Dermapharm Is Engaged In A Constructive Dialogue With The Regulator
Refile: BUZZ-Dermapharm Holding slips after BaFin's audit